• 26028 Citations
  • 90 h-Index
1975 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Eric Hollander is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Obsessive-Compulsive Disorder Medicine & Life Sciences
Autistic Disorder Medicine & Life Sciences
Serotonin Uptake Inhibitors Medicine & Life Sciences
Gambling Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Body Dysmorphic Disorders Medicine & Life Sciences
Placebos Medicine & Life Sciences
Serotonin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1975 2011

trainee
statistics
didactics
research project
science

Greater New York Autism Research Center of Excellence

Hollander, E., Buxbaum, J. D., Schmeidler, J., Laruelle, M. & Buxbaum, J. D.

National Institutes of Health

5/13/034/30/09

Project: Research project

Autistic Disorder
Fluoxetine
Research
Serotonin
Placebos
Valproic Acid
Autistic Disorder
Placebos
Impulsive Behavior
Aggression
Body Dysmorphic Disorders
Drug Therapy
Paranoid Schizophrenia
Fluoxetine
Obsessive-Compulsive Disorder

Publications 1984 2019

Compulsivity in alcohol use disorder and obsessive compulsive disorder: Implications for neuromodulation

Burchi, E., Makris, N., Lee, M., Pallanti, S. & Hollander, E., Jan 30 2019, In : Frontiers in Behavioral Neuroscience. 13, 70.

Research output: Contribution to journalArticle

Open Access
Obsessive-Compulsive Disorder
Alcohols
Therapeutics
Diagnostic and Statistical Manual of Mental Disorders
Habits
1 Citation (Scopus)

Early intervention for obsessive compulsive disorder: An expert consensus statement

Fineberg, N. A., Dell'Osso, B., Albert, U., Maina, G., Geller, D., Carmi, L., Sireau, N., Walitza, S., Grassi, G., Pallanti, S., Hollander, E., Brakoulias, V., Menchon, J. M., Marazziti, D., Ioannidis, K., Apergis-Schoute, A., Stein, D. J., Cath, D. C., Veltman, D. J., Van Ameringen, M. & 5 others, Fontenelle, L. F., Shavitt, R. G., Costa, D., Diniz, J. B. & Zohar, J., Jan 1 2019, In : European Neuropsychopharmacology.

Research output: Contribution to journalArticle

Obsessive-Compulsive Disorder
Consensus
Psychological Stress
Tertiary Prevention
Poisons

Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)

Dell'Osso, B., Vismara, M., Benatti, B., Cirnigliaro, G., Grancini, B., Fineberg, N. A., Van Ameringen, M., Hollander, E., Stein, D. J., Menchon, J. M., Rodriguez, C. I., Nicolini, H., Lanzagorta, N., Pallanti, S., Grassi, G., Lochner, C., Marazziti, D., Hranov, G., Karamustafalioglu, O., Hranov, L. & 1 others, Zohar, J., Jan 1 2019, In : CNS Spectrums.

Research output: Contribution to journalArticle

Obsessive-Compulsive Disorder
Comorbidity
Hospitalization
Bipolar and Related Disorders
Therapeutics

Pharmacological treatment of body dysmorphic disorder

Hong, K., Nezgovorova, V., Uzunova, G., Schlussel, D. & Hollander, E., Jan 1 2019, In : Current Neuropharmacology. 17, 8, p. 697-702 6 p.

Research output: Contribution to journalReview article

Body Dysmorphic Disorders
Fluoxetine
Obsessive-Compulsive Disorder
Antidepressive Agents
Pharmacology

Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments

Dong, N., Nezgovorova, V., Hong, K. & Hollander, E., Jan 1 2019, In : Expert Opinion on Pharmacotherapy.

Research output: Contribution to journalArticle

Body Dysmorphic Disorders
Secondary Prevention
Drug Therapy
Serotonin Uptake Inhibitors
Therapeutics